The company’s ClearStain and ReStain platforms aim to support tissue preservation, molecular workflow efficiency and multi-omic research by generating virtual stains from unstained or existing H&E slides....
There is a growing tendency to seek a second opinion, especially in oncology, where treatment options may include surgery, chemotherapy, radiation therapy, immunotherapy, targeted therapy, or genetic profiling...
The next-generation hematology platform builds on the XN-Series with higher throughput, enhanced analytics and modular workflow support for high-complexity laboratories. ...
Recent advancements around pTau217 assays are drawing significant attention for their ability to detect amyloid pathology through minimally invasive blood testing...
The designation supports Gene Solutions’ US development pathway for its multi-omic blood-based test designed to detect cancer-associated signals across 10 cancer types. ...
Open-access digital platform supports policymakers, researchers and the public in exploring the health, economic and education impacts of pandemic response strategies....
POWER CAD I study will evaluate feasibility of the Pulse IVL™ system in patients with severely calcified coronary arterial disease...
RAMP UP programme with Hitachi High-Tech America supports electronic genome mapping studies in AML and MDS ...
Collaboration aims to improve accessibility and adoption of multi-cancer early detection solutions through a broader practitioner network ...
Investment manager Michael Lamprecht highlights structural funding gaps, regulatory fragmentation, and the need for commercially viable antimicrobial resistance strategies ...
